10 research outputs found

    Partisanship Predicts COVID-19 Vaccine Brand Preference: The Insightful Case of Argentina

    Get PDF
    The COVID-19 pandemic highlighted the importance of not only diminishing the resistance to vaccine adoption in general, but also to reduce both real and perceived barriers to a swift vaccination campaign. One major problem faced by health systems around the world was that people’s preferences for a specific brand of vaccine often delayed vaccination efforts as people canceled or delayed appointments to receive their preferred brand. Therefore, in the event of another pandemic, it is important to know which factors influence preferences for specific vaccine brands. Previous literature showed that consumers choose products that are congruent with their self-concept, which includes their political affiliation. Given that the discourse around vaccine brands has been strongly politicized during the pandemic, in our work, we test whether partisanship influences preferences for COVID-19 vaccine brands. To test this, we collected survey data from Argentina (N = 432), a country with a clear bipartisan structure and where a variety of vaccine brands were administered, both from Western and Eastern laboratories. We found that supporters of the ruling party, which had strong ties with Eastern countries such as Russia and China, perceived Eastern vaccine brands (e.g., Sputnik V) to be more effective and safe than Western ones (e.g., Pfizer) whereas the contrary was true for supporters of the opposition. Our results also showed that supporters of the opposing party were more likely to wish to hypothetically switch vaccines, to delay their appointment in case of not receiving their preferred brand, and to disapprove of their local vaccination campaign. Our results demonstrate that political party affiliation biases perceptions of both vaccine brands’ quality and vaccination campaign effectiveness. We anticipate that our results can inform public policy strategies when it comes to an efficient vaccine supply allocation, as political affiliation is a measurable and predictable consumer trait.Este artículo se encuentra publicado en SSRN 4292235

    Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study

    Get PDF
    Funder: European Society of Intensive Care Medicine; doi: http://dx.doi.org/10.13039/501100013347Funder: Flemish Society for Critical Care NursesAbstract: Purpose: Intensive care unit (ICU) patients are particularly susceptible to developing pressure injuries. Epidemiologic data is however unavailable. We aimed to provide an international picture of the extent of pressure injuries and factors associated with ICU-acquired pressure injuries in adult ICU patients. Methods: International 1-day point-prevalence study; follow-up for outcome assessment until hospital discharge (maximum 12 weeks). Factors associated with ICU-acquired pressure injury and hospital mortality were assessed by generalised linear mixed-effects regression analysis. Results: Data from 13,254 patients in 1117 ICUs (90 countries) revealed 6747 pressure injuries; 3997 (59.2%) were ICU-acquired. Overall prevalence was 26.6% (95% confidence interval [CI] 25.9–27.3). ICU-acquired prevalence was 16.2% (95% CI 15.6–16.8). Sacrum (37%) and heels (19.5%) were most affected. Factors independently associated with ICU-acquired pressure injuries were older age, male sex, being underweight, emergency surgery, higher Simplified Acute Physiology Score II, Braden score 3 days, comorbidities (chronic obstructive pulmonary disease, immunodeficiency), organ support (renal replacement, mechanical ventilation on ICU admission), and being in a low or lower-middle income-economy. Gradually increasing associations with mortality were identified for increasing severity of pressure injury: stage I (odds ratio [OR] 1.5; 95% CI 1.2–1.8), stage II (OR 1.6; 95% CI 1.4–1.9), and stage III or worse (OR 2.8; 95% CI 2.3–3.3). Conclusion: Pressure injuries are common in adult ICU patients. ICU-acquired pressure injuries are associated with mainly intrinsic factors and mortality. Optimal care standards, increased awareness, appropriate resource allocation, and further research into optimal prevention are pivotal to tackle this important patient safety threat

    Partisanship predicts COVID-19 vaccine brand preference: the case of Argentina

    Get PDF
    Abstract The COVID-19 pandemic underscored the significance of overcoming vaccine adoption resistance and addressing real and perceived barriers for efficient vaccination campaigns. One major problem faced by health systems around the world was that people’s preferences for a specific brand of vaccine often delayed vaccination efforts as people canceled or delayed appointments to receive their preferred brand. Therefore, in the event of another pandemic, it is important to know which factors influence preferences for specific vaccine brands. Previous literature showed that consumers choose products that are congruent with their self-concept, which includes their political affiliation. Given that the discourse around vaccine brands has been strongly politicized during the pandemic, in our work, we test whether partisanship influences preferences for COVID-19 vaccine brands. To test this, we collected survey data from Argentina (N = 432), a country with a clear bi-partisan structure and where a variety of vaccine brands were administered, both from Western and Eastern laboratories. We found that supporters of the ruling party, which had strong ties with Eastern countries such as Russia and China, perceived Eastern vaccine brands (e.g., Sputnik V) to be more effective and safer than Western ones (e.g., Pfizer) whereas the contrary was true for supporters of the opposition. Our results also showed that supporters of the opposing party were more likely to wish to hypothetically switch vaccines, to delay their appointment in case of not receiving their preferred brand, and to disapprove of their local vaccination campaign. Our results demonstrate that political party affiliation biases perceptions of both vaccine brands’ quality and vaccination campaign effectiveness. We anticipate that our results can inform public policy strategies when it comes to an efficient vaccine supply allocation, as political affiliation is a measurable and predictable consumer trait

    Correction to: Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study (Intensive Care Medicine, (2021), 47, 2, (160-169), 10.1007/s00134-020-06234-9)

    No full text
    The original version of this article unfortunately contained a mistake. The members of the ESICM Trials Group Collaborators were not shown in the article but only in the ESM. The full list of collaborators is shown below. The original article has been corrected
    corecore